HKD 54.6
(-2.5%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 9.61 Billion | 10.1 Billion | 10.46 Billion | 9.69 Billion | 11.69 Billion | 8.29 Billion |
Net Income | 6.81 Billion | 5.86 Billion | 7.75 Billion | 6.27 Billion | 5.67 Billion | 2.81 Billion |
Depreciation & Amortization | 2.74 Billion | 2.55 Billion | 2.23 Billion | 2.05 Billion | 1.76 Billion | 1.28 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 9 Million | 21 Million | 49 Million | 70 Million | 74 Million | 19 Million |
Change in working capital | -1.14 Billion | -197 Million | -1.55 Billion | -1.54 Billion | 1.71 Billion | -522 Million |
Other non-cash items | 421 Million | 1.85 Billion | 1.97 Billion | 2.83 Billion | 2.46 Billion | 4.69 Billion |
Investing Cash Flow | -4.84 Billion | -5.72 Billion | -6.76 Billion | -6.49 Billion | -6.69 Billion | -6.6 Billion |
Investments in PPE | -6.49 Billion | -6.24 Billion | -6.25 Billion | -5.51 Billion | -7.27 Billion | -5.96 Billion |
Acquisitions | 5 Million | -81 Million | -726 Million | -636 Million | -1.17 Billion | -488 Million |
Investment purchases | -11.46 Billion | -16.49 Billion | -12.34 Billion | -10.52 Billion | -20.11 Billion | -22.95 Billion |
Sales/Maturities of investments | 12.37 Billion | 17.12 Billion | 12.53 Billion | 10.48 Billion | 20.51 Billion | 22.96 Billion |
Other Investing Activities | 1.64 Billion | 596 Million | 213 Million | -340 Million | 1.75 Billion | -150 Million |
Financing Cash Flow | -3.14 Billion | -5.02 Billion | -3.63 Billion | -1.9 Billion | -5.54 Billion | -1.77 Billion |
Debt repayment | -1.8 Billion | -1.21 Billion | -487 Million | -1.08 Billion | -2.72 Billion | -387 Million |
Dividends payments | -2.97 Billion | -2.65 Billion | -2.82 Billion | -1.71 Billion | -1.17 Billion | -952 Million |
Common Stock Repurchased | -229 Million | - | - | -17 Million | -151 Million | -78 Million |
Common Stock Issuance | 20 Million | 48 Million | 90 Million | 96 Million | -99 Million | 33 Million |
Other Financing Activities | -1.73 Billion | -1.15 Billion | -1.29 Billion | -1.25 Billion | -1.5 Billion | -1.13 Billion |
Accounts receivables | -675 Million | -405 Million | -1.33 Billion | -1.26 Billion | 1.48 Billion | -1.65 Billion |
Accounts payables | - | - | - | - | - | - |
Inventory | -56 Million | -201 Million | -234 Million | -117 Million | 216 Million | -404 Million |
Other working capital | -410 Million | 409 Million | 18 Million | -167 Million | 12 Million | 1.54 Billion |
Cash at beginning of period | 8.05 Billion | 8.68 Billion | 8.63 Billion | 7.37 Billion | 7.92 Billion | 7.97 Billion |
Cash at end of period | 9.68 Billion | 8.05 Billion | 8.68 Billion | 8.63 Billion | 7.37 Billion | 7.92 Billion |
Capital Expenditure | -6.49 Billion | -6.24 Billion | -6.25 Billion | -5.51 Billion | -7.27 Billion | -5.96 Billion |
Effect of forex changes on cash | 13 Million | 17 Million | -10 Million | -47 Million | 3 Million | 30 Million |
Net cash flow / Change in cash | 1.63 Billion | -628 Million | 54 Million | 1.25 Billion | -550 Million | -52 Million |
Free Cash Flow | 3.11 Billion | 3.86 Billion | 4.21 Billion | 4.18 Billion | 4.41 Billion | 2.33 Billion |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.57 Billion | 6.81 Billion | 3.48 Billion | 3.33 Billion | 5.86 Billion | 2.76 Billion |
Depreciation & Amortization | 1.49 Billion | 2.74 Billion | 1.32 Billion | 1.42 Billion | 2.55 Billion | 1.29 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 9 Million | 754 Million | 16 Million | 21 Million | 7 Million |
Change in working capital | - | -1.14 Billion | -1.14 Billion | - | -197 Million | -197 Million |
Other non-cash items | -805 Million | 421 Million | 1.18 Billion | -768 Million | 1.85 Billion | 3.09 Billion |
Investing Cash Flow | -1.49 Billion | -4.84 Billion | -2.78 Billion | -2.06 Billion | -5.72 Billion | -4.47 Billion |
Investments in PPE | -2.3 Billion | -6.49 Billion | -3.44 Billion | -3.05 Billion | -6.24 Billion | -3.76 Billion |
Acquisitions | - | 5 Million | 28 Million | -23 Million | -81 Million | 27 Million |
Investment purchases | - | -11.46 Billion | - | - | -16.49 Billion | - |
Sales/Maturities of investments | - | 12.37 Billion | - | - | 17.12 Billion | - |
Other Investing Activities | 808 Million | 1.64 Billion | 632 Million | 1 Billion | 596 Million | -729 Million |
Financing Cash Flow | -3.39 Billion | -3.14 Billion | -4.05 Billion | 915 Million | -5.02 Billion | -5.95 Billion |
Debt repayment | -2.36 Billion | -1.8 Billion | - | -1.69 Billion | -1.21 Billion | - |
Dividends payments | - | -2.97 Billion | -2.97 Billion | - | -2.65 Billion | -2.65 Billion |
Common Stock Repurchased | -215 Million | -229 Million | -229 Million | - | - | - |
Common Stock Issuance | - | 20 Million | - | - | 48 Million | - |
Other Financing Activities | -811 Million | -1.73 Billion | -852 Million | -784 Million | -1.15 Billion | -3.3 Billion |
Accounts receivables | - | -675 Million | -675 Million | - | -405 Million | -405 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | -56 Million | -56 Million | - | -201 Million | -201 Million |
Other working capital | - | -410 Million | -410 Million | - | 409 Million | 409 Million |
Cash at beginning of period | 9.68 Billion | 8.05 Billion | 10.93 Billion | -1.44 Billion | 8.68 Billion | -231.65 Million |
Cash at end of period | 8.07 Billion | 9.68 Billion | -624.5 Million | 1.44 Billion | 8.05 Billion | -1.99 Billion |
Capital Expenditure | -2.3 Billion | -6.49 Billion | -3.44 Billion | -3.05 Billion | -6.24 Billion | -3.76 Billion |
Effect of forex changes on cash | 5 Million | 13 Million | -20 Million | 33 Million | 17 Million | -44 Million |
Net cash flow / Change in cash | -1.61 Billion | 1.63 Billion | -11.56 Billion | 2.88 Billion | -628 Million | -1.75 Billion |
Free Cash Flow | 961 Million | 3.11 Billion | 2.16 Billion | 948 Million | 3.86 Billion | 3.18 Billion |
WSBCP
603855
2276
CSW-B
3934
SESMF